跳至主要内容
临床试验/IRCT201106156807N1
IRCT201106156807N1已完成2 期

The comparison of metronidazole and the combination of metronidazole and probitic on treatment of bacterial vaginosis

The Shahid Beheshti University of Medical Science & Health Service0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • 1- bacterial vaginosis approval based on Amsel's criterias 2-married women aged 18-45 years 3-having one partner 4-absence of pregnancy and breast feeding 5-absence of mensturation at the time of attendance 6-not using vaginal drug, antibiotics and immonosupressive drugs since 14 days before starting the research 7-not having intercourse or using vaginal douche within the last 24 hours 8-absence of other types of candidias and trichmonas vaginitis at the time of study 9-not using alchohol , anticoagulant like comadin and disulfiram 10-absence of any diagnose medical disease such as diabetis , blood dyscrasia , thyroid disorders and liver disease by asking a patient 11-not using IUD. Exclusion criteria: 1-drug intolerancy 2-pregnancy during therapy 3-compulsion to use antibiotics

排除标准

  • 未提供

研究者

发起方
The Shahid Beheshti University of Medical Science & Health Service

相似试验